Cancer screening in patients with cancer

Japanese Journal of Clinical Oncology

Volumn 32, Issue 4, 2002, Pages 118-119

  Tachimori, Yuji ^a  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P53; ACID ANHYDRIDE HYDROLASE; TUMOR PROTEIN;

ALCOHOL CONSUMPTION; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; EDITORIAL; ENDOSCOPY; ENVIRONMENTAL FACTOR; ESOPHAGUS CARCINOMA; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; MULTIPLE CANCER; POSITRON EMISSION TOMOGRAPHY; SMOKING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; GENETICS; NEOPLASM; NOTE; SECOND CANCER;

ACID ANHYDRIDE HYDROLASES; GENES, P53; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NEOPLASMS, SECOND PRIMARY;

EID: 0036527914     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/hyf042     Document Type: Editorial

References (15)

1. Warren S, Gates O. Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer 1932;16:1358-414.
2. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953;6:963-8.
3. Morita M, Saeki H, Mori M, Kuwano H, Sugimachi K. Risk factors for esophageal cancer and the multiple occurrence of carcinoma in the upper aerodigestive tract. Surgery 2002;131(1 Suppl):S1-S6.
4. Sardi I, Franchi A, Bocciolini C, Mechi C, Frittelli A, Bruschini L, et al. Microsatellite instability as biomarker for risk of multiple primary malignancies of the upper aerodigestive tract. Oncol Rep 2001;8:393-9.
5. Kokawa A, Yamaguchi H, Tachimori Y, Kato H, Watanabe H, Nakanishi Y. Other primary cancers occurring after treatment of superficial oesophageal cancer. Br J Surg 2001;88:439-43.
6. Ross JS, McKenna BJ. The HER-2/neu oncogene in tumors of the gastrointestinal tract. Cancer Invest 2001;19:554-68.
7. Kagei K, Hosokawa M, Shirato H, Kusumi T, Shimizu Y, Watanabe A, et al. Efficacy of intense screening and treatment for synchronous second primary cancers in patients with esophageal cancer. Jpn J Clin Oncol 2002;32:120-27.
8. Makuuchi H, Machimura T, Shimada H, Mizutani K, Chino O, Kise Y, et al. Endoscopic screening for esophageal cancer in 788 patients with head and neck cancers. Tokai J Exp Clin Med 1996;21:139-45.
9. Kumagai Y, Kawano T, Nakajima Y, Nagai K, Inoue H, Nara S, et al. Multiple primary cancers associated with esophageal carcinoma. Surg Today 2001;31:872-6.
10. Fekete F, Sauvanet A, Kaisserian G, Jauffret B, Zouari K, Berthoux L, et al. Associated primary esophageal and lung carcinoma: a study of 39 patients. Ann Thorac Surg 1994;58:837-42.
11. Kuwano H, Nozoe T, Sumiyoshi K, Yasuda M, Watanabe M, Ohno S, et al. Oesophageal cancer coexisting with colorectal lesions. Eur J Surg 1996;162:797-800.
12. Saikawa M, Ebihara S, Yoshizumi T, Ohyama W. Multiple primary cancers in patients with squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 1991;82:40-5.
13. Kodama M, Kodama T. The interference of geographical changes of cancer risk in tumor etiology in Japan. Anticancer Res 1993;13:1035-42.
14. Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-10.
15. Stokkel MP, de Klerk JM, Hordijk GJ. Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology. Eur Arch Otorhinolaryngol 2000;257:552-4.